CeriBell Inc
NASDAQ:CBLL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CeriBell Inc
NASDAQ:CBLL
|
US |
|
Jiangsu Yangnong Chemical Co Ltd
SSE:600486
|
CN |
|
L
|
Loyal Textile Mills Ltd
NSE:LOYALTEX
|
IN |
|
C
|
CA Sales Holdings Ltd
JSE:CAA
|
ZA |
|
Chiho Environmental Group Ltd
HKEX:976
|
HK |
|
C
|
Camelot Electronics Technology Co Ltd
SZSE:301282
|
CN |
|
Yeal Electric Co Ltd
SZSE:300923
|
CN |
|
Shriram Finance Ltd
NSE:SHRIRAMFIN
|
IN |
|
M
|
Mitsubishi Research Institute Inc
TSE:3636
|
JP |
|
D
|
Deutsche Telekom AG
OTC:DTEGY
|
DE |
|
AVIT Ltd
SZSE:300264
|
CN |
|
Hiconics Eco-energy Technology Co Ltd
SZSE:300048
|
CN |
|
A
|
Axis Real Estate Investment Trust
KLSE:AXREIT
|
MY |
|
S
|
Sarawak Cable Bhd
KLSE:SCABLE
|
MY |
|
Ardent Leisure Group Ltd
ASX:ALG
|
AU |
|
Y
|
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
|
CN |
|
K
|
Keli Sensing Technology Ningbo Co Ltd
SSE:603662
|
CN |
|
CTS Corp
NYSE:CTS
|
US |
|
Z
|
ZRP Printing Group Co Ltd
SZSE:301223
|
CN |
|
A
|
After You Public Co Ltd
SET:AU
|
TH |
|
Nanyo Corp
TSE:7417
|
JP |
|
Y
|
YGSOFT Inc
SZSE:002063
|
CN |
|
China Feihe Ltd
HKEX:6186
|
CN |
|
Advanced Info Service PCL
SET:ADVANC
|
TH |
CeriBell Inc
Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The company is focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The company is focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
